Skip to content

Clinical trials

Trials in Luxembourg

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Country / region: Luxembourg Clear all

175 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20031
20044
20052
20066
20072
20087
20096
20107
201110
20126
20135
201415
20155
20169
201713
20185
20196
20207
202113
20225
20238
20244
202510
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed102
Recruiting19
Unknown status18
Active, not recruiting13
Terminated11
Not yet recruiting4
Approved for marketing3
Withdrawn2
No longer available2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Luxembourg Institute of Health27
Hoffmann-La Roche10
Bayer7
Centre Francois Baclesse, Luxembourg7
Centre Hospitalier du Luxembourg5
Novadip Biosciences4
Novo Nordisk A/S4
University of Luxembourg4
AstraZeneca3
Cliniques universitaires Saint-Luc- Université Catholique de Louvain3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms11
Diabetes Mellitus, Type 19
Carcinoma, Non-Small-Cell Lung8
COVID-196
Diabetes Mellitus6
Neoplasms6
Parkinson Disease6
Prostatic Neoplasms6
Arthritis, Rheumatoid5
Cardiovascular Diseases5

Trials

Showing 76 to 100 of 175. Each trial links to its page on Pharma Observatory.

75 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.